Please login to the form below

Not currently logged in
Email:
Password:

FDA clears test for ovarian cancer

The FDA has approved a test that can help detect ovarian cancer in a pelvic mass already known to require surgery

The US Food and Drug Administration (FDA) has approved a test that can help detect ovarian cancer in a pelvic mass that is already known to require surgery. Named OVA1, the test helps patients and healthcare professionals decide what type of surgery should be done and by whom.

OVA1 identifies some women who will benefit from referral to a gynaecological oncologist for their surgery, despite negative results from other clinical and radiographic tests for ovarian cancer. Conversely, if there is a negative OVA1 result but other test results suggest cancer, patients would still be referred to an oncologist.

OVA1 should be used by primary care physicians or gynaecologists as an adjunctive test to complement, not replace other diagnostic and clinical procedures.

The test is intended only for women 18 years and older who are already selected for surgery because of their pelvic mass. It is not intended for ovarian cancer screening or for a definitive diagnosis of ovarian cancer.

14th September 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OPEN Access Consulting

OPEN Access Consulting is a specialist market access agency within the OPEN Health Group. As value communications experts we specialise...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...

Infographics